James A. Schoeneck

Schoeneck was CEO of Depomed Inc. from 2011 until 2017. Previously, he served as CEO of BrainCells Inc., CEO of ActivX BioSciences. Earlier, he was president and CEO of Prometheus Laboraories Inc. and VP and general manager of immunology at Centocor Inc. (now Janssen Biotech Inc.). He currently serves on the board of FibroGen.

  • October 2020

Added to: Calidi Biotherapeutics - San Diego, CA

Calidi is a clinical-stage immuno-oncology company focused on delivering oncolytic virus-based immunotherapies for difficult-to-treat cancers.